- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical Pharmacokinetic Studies of Enzalutamide ; volume:54 ; number:10 ; day:28 ; month:4 ; year:2015 ; pages:1043-1055 ; date:10.2015
Clinical pharmacokinetics ; 54, Heft 10 (28.4.2015), 1043-1055, 10.2015
- Creator
-
Gibbons, Jacqueline A.
Ouatas, Taoufik
Krauwinkel, Walter
Ohtsu, Yoshiaki
Walt, Jan-Stefan van der
Beddo, Vanessa
Vries, Michiel de
Mordenti, Joyce
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-015-0271-5
- URN
-
urn:nbn:de:101:1-2019102815200610178110
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gibbons, Jacqueline A.
- Ouatas, Taoufik
- Krauwinkel, Walter
- Ohtsu, Yoshiaki
- Walt, Jan-Stefan van der
- Beddo, Vanessa
- Vries, Michiel de
- Mordenti, Joyce
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer